Yellow fever vaccin
Ended Awarded Last action
- Contract number
- SPE2DP26F0606
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,670
Award facts
- Contract value 100% obligated
- $1,670.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $1,670.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of yellow fever vaccine (YF-VAX). This delivery order, awarded on November 7, 2025, with an ultimate completion date of November 24, 2025, was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was recently awarded on November 13, 2025, with a ceiling value of $499,999,999 and completion through December 31, 2036.
DMS Pharmaceutical Group serves as a critical regional pharmaceutical supplier for Department of Defense military healthcare operations, with demonstrated expertise in distributing a comprehensive portfolio of pharmaceuticals and medical consumables including branded and generic prescription medications, biologics, vaccines, and specialty products. The PPV-G GEN V represents a $30.3 billion acquisition strategy under which the Defense Logistics Agency has established multiple regional prime vendor contractors to support recurring medical supply needs of military healthcare facilities worldwide. Through its established performance on numerous delivery orders spanning diverse therapeutic categories and product lines, DMS Pharmaceutical Group has demonstrated its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DP26F0606?
SPE2DP26F0606 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on November 7, 2025.
How much is contract SPE2DP26F0606 worth?
The government has obligated $1,670 on SPE2DP26F0606.
Is contract SPE2DP26F0606 an order under another contract?
Yes. SPE2DP26F0606 is a delivery order under SPE2DX25D9900, an indefinite delivery contract.
Was contract SPE2DP26F0606 competed?
The extent of competition for SPE2DP26F0606 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award